Global China Capital Markets: Domestic Issuances

King & Wood Mallesons remains top of the market for domestic, Hong Kong and overseas issuances. The team fields a deep bench with top-notch expertise across the securities arena, leveraging its global network to advise clients on complex onshore and offshore listings, refinancings and private equity financings. It is particularly well versed in pre-IPO structuring. The firm maintains a strong reputation for structured finance and securitisation work through public offerings and private placements. Its expertise is in high demand among issuers and underwriters, and also extends to bond issuances for both state-owned and privately owned clients. China International Capital Corporation (CICC), ZJMI Environmental Energy and Cheerwin Group are examples of the practice's clients.

AllBright Law Offices is proficient in handling debt and equity transactions as well as M&A and the restructuring of listed companies. The firm is frequently mandated by underwriters on asset securitisation in the financial services, real estate and transportation sectors, among others. The capital markets team continues to assist domestic clients in industries ranging from banking and financial services to healthcare and energy on domestic listings. It deals with A-share listings on the Shanghai and Shenzhen Stock Exchanges. Its clients include Jiangsu GDK Biotechnology, Suzhou Huaya Intelligence Technology and Righton Gene.

Jia Yuan Law Offices covers the full range of domestic and overseas transactions, including IPOs, non-public offerings and the restructuring of public companies. The law firm is adept at advising on listings on the New York Stock Exchange. The team predominantly acts for state-owned enterprise clients. It is equally capable with regard to A-share and H-share issuances. Jia Yuan assists corporate clients in a wide variety of industries, including technology, financial services and pharmaceuticals, such as Dongguan Rural Commercial Bank, Asieris Pharmaceuticals and Tuya.

Fangda Partners is a solid corporate practice with extensive experience in overseas equity and debt offerings, including IPOs and H-share convertible issuance. It is known for advising on listings in the USA, Singapore and Hong Kong. The team is equipped to handle corporate bonds, perpetual bonds and panda bonds issuances. Additionally, it is mandated by state-owned investment firms to handle structured finance projects and is sought after in particular for its expertise in asset-backed securitisation. Fangda Partners continues to serve a host of leading pharmaceutical, biotech and internet companies, as well as financial institutions. New Horizon Health, Aztech Global and Asian Development Bank are examples of its clients. The law firm is active in representing both issuers and underwriters in the domestic market, especially with regard to companies delisted from overseas markets returning to the domestic market.

Llinks Law Offices offers experience in acting on acquisitions of listed companies, private equity matters, domestic IPOs and restructurings. It advises on a wide range of debt and equity issuances in the domestic market. The team works with clients from a variety of industries ranging from chemicals and pharmaceuticals to electronics and energy, such as Hunan Dajiaweikang Pharmaceutical Industry, MicroTech Medical (Hangzhou) and Ganfeng Lithium. It is noted for its expertise in handling corporate and convertible bond issuances.

The Dentons China team boasts skill in dealing with a range of financial instruments, regularly dealing with futures, options, forwards, swaps, ABS and RMBS. It is routinely instructed by a large range of state-owned enterprises and private banks to handle securitisation work, including China Orient Asset Management. Additionally, Dentons China is called upon to advise on domestic equity and debt offerings, including IPOs and corporate bond issuances. The firm has offices in several major cities, including Beijing, Shanghai, Nanjing, Guangzhou and Shenzhen, enabling service to regional as well as national banks.

Hai Run Law Firm has an established practice that handles both debt and equity issuances. It is acknowledged for its expertise in equity offerings, with experience handling IPOs on the Beijing and Shanghai stock exchanges. Its impressive client roster features corporates from the TMT, biotech and chemicals sectors, such as Hangzhou Bio-Sincerity Pharma-Tech, Huafon Chemical and Luohe Letone Hydraulic Technology.